Hemodynamics and risk assessment two years after initiation of upfront ambrisentan-tadalafil in pulmonary arterial hypertension
- Upfront combination therapy with ambrisentan and tadalafil has been reported to improve pulmonary arterial hypertension (PAH) patients more than with either drug alone. However, little is known about long-term associated changes in hemodynamics and risk assessment scores.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Michele D'Alto, Roberto Badagliacca, Francesco Lo Giudice, Paola Argiento, Gavino Casu, Marco Corda, Michele Correale, Stefano Ghio, Alessandra Greco, Mariangela Lattanzio, Valentina Mercurio, Giuseppe Paciocco, Silvia Papa, Renato Prediletto, Emanuele Ro Tags: Original Clinical Science Source Type: research
More News: Cardiology | Cialis | Heart | Heart Transplant | Hypertension | Lung Transplant | Science | Transplant Surgery | Transplants